3M FLUOROCHEMICAL SUBMISSIONS February, 2002 - May, 2004 INDEX OF 3M'S 2002-2004 AR-226 DOCKET SUBMISSIONS BY DATE FEBRUARY 2002 February 1, 2002 Click on Study Title to View Report Back to Menu TSCA 8(e) Notice of Draft Reports of Reproduction Studies of Northern Bobwhite and Mallard and PFOS February 28, 2002 TSCA 8(e) Notice of Draft Final Report on Ammonium Perfluorooctanoate (APFO) in an Oral (Gavage) TwoGeneration Reproduction Study in Rats.

Laboratory R eport-R evision 1 Analytical Report o f Data for PFOS Dietary LC50 Study in Northern Bobwhite (Sera and Liver) Laboratory Report No.

AR226-2159 Robert F Pinchot 07/12/2001 12:33 PM To: David M Rurak/AE/DuPont@DuPont, H David Ramsey/SE/DuPont@DuPont, Stephen J Gfesy/AE/DuPont@DuPont, Robert L Ritchey/CL/DuPorrt@DuPont, John J Mentink/CL/DuPont@DuPont, Chris E Shoop/AE/DuPont@DuPont, Bernard J Reilly/AE/DuPont@DuPont, John R Bowman/AE/DuPont@DuPont, Andrea V Maiinowski/AE/DuPont@DuPont, Oscar T Garza/AE/DuPont@DuPont cc: Maurice Astorga/AE/DuPont@DuPont, Debbie J Mulrooney/AE/DuPont@DuPont, Catherine A Barton/AE/DuPont@DuPont Subject: Air dispersion modeling strategy I have talked with a number of people yesterday and today concerning modeling of APFO emissions from Washington Works.

AR226-2210 Robert Pinchot 11/05/2001 03:02 PM ________ ____________________ To: Debbie J Mulrooney/AE/DuPont@DuPont, Steven L Grise/AE/DuPont@DuPont, Mary A Kaiser/AE/DuPont@DuPont, Ron J Buchanan/AE/DuPont@DuPont>Roger J Zipfel/AE/DuPont@DuPont cc: Ta-W ei Fu/SE/DuPont@DuPont, Bernard J Reilly/AE/DuPont@DuPont, David M Rurak/AE/DuPont@DuPont, Chris E Shoop/AE/DuPont@DuPont, Robert L Ritchey/CL/DuPont@DuPont, Charles J Zarzecki/AE/DuPont@DuPont, Stephen T Breske/AE/DuPont@DuPont Subject: Mulit Media Consent Order APFO data requirements It looks like we are getting close to agreeing on the requirements for a Consent order between the W V Dept, of Environmental Protection, the W V Department of Health and Human Resources, and DuPont.

AR226-2330 DISPERSION MODELING PROTOCOL Plant-wide C8 Emissions DuPont Chambers Works Facility Deepwater, New Jersey Prepared by: DuPont Engineering Technology (DuET) Environmental Section Wilmington, DE 19898 April 9,2003 E ID 747779 DuPont Chambers Works Air Quality Modeling Protocol The following sections describe the dispersion modeling methodology to be employed in order to assess the locations o f maximum ambient air concentrations resulting from C8 emissions at the DuPont Chambers Works facility located in Deepwater, New Jersey. . 1. .

AR226-2521 C-8 DATA SUMMARY REPORT CONSENT ORDER GWR-2001-019 DUPONT WASHINGTON WORKS FACILITY AND LOCAL, LETART AND DRY RUN LANDFILLS ') Dale: February 2003 Project No.: 7423 18983753.00036 CORPORATE REMEDIATION GROUP An Alliance between DuPont and URS Diamond Barley Mill Plaza, Building 27 Wilmington, Delaware 19805 A SH 021621 BID639853 0 -8 Data Summary Report Table of Contents TABLE OF CONTENTS Executive Summary.... ,......................................... 1.0 Introduction ............................... 1.1 Document Organization....................... 2.0 C-8 Analyses and Analytical Reporting,,...,,,,, 2.1 Independent Quality Assurance Review 3.0 Washington Works Facility....... .......................................... .......-.................... 7 3.1 Introduction...................................................................... ................................ 7 3.2 Task A: Groundwater Well and Water-Use Surveying and C-8 Sampling,...,.,,,............................................. ...................................................... 7 3.2.1 One-Mile Radius Sampling............................... 7 3.2.2 Two-Mile Radius Sampling.... ................. 8 3.2.3 Ohio One-Mile Sampling.................................................................... 9 3.2.4 Ohio Two Mile Sampling ................. ................................... --9 3.3 Task B: Assessment of Existing Groundwater and Surface-water Monitoring Data....... ...................,...,............................................................ 10 3.3.1 Monitoring o f C-8 in Groundwater and Surface Water.....................10 3.3.2 Ohio River Water Quality,.....,...................................... 12 3.3.3 Public Water Supply Sampling.............................................. .. 13 3.4 Task C: Plume Identification/Groundwater Assessment..................14 3.4.1 Installation ofNew Wells at the Washington Works Facility...........14 3.4.2 Hydrogeologic Testing of New Wells at the Washington Works Facility...................................................... 14 3.4.3 Washington Works Groundwater Model Refinement....... ......... 15 3.4.4 Surface-water Field Reconnaissance at the Washington Works Facility........ ........................... 15 3.4.5 C-8 Monitoring in Groundwater and Surface Water at the Washington Works Facility...................................... 15 3.4.6 Washington Works Facility Site Conceptual Model Refinement....,..,....,....,........,.,.........,........ 16 3.5 Revised Site Conceptual Model......................... 16 3.5.1 Current Environmental Setting...........................................................16 3.5.2 Current Human Health and Ecological Exposure Pathways............. 21 3.6 Washington Works Facility Summary............. 24 4.0 Local Landfill................................... . ****>**!

AR226-2561 September 4, 2001 Samantha P.

AR226-3559 UO Jl. ???

3M General Offices 3S6Mi5.UPCaeu3m3l.eM1i1N1055144-1000 _ 3 T 7 September 24, 2003 IJ By Hand Delivery Document Processing Center (7407) Office of Poilution, Prevention and Toxics U.S.

3M Corporate Toxicology and Regulatory Services 3M Center.

RECEIVED irrt cno OfrJUL-5 AHII: 22 AK 2Z _ 373Z Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing Workers Final Report Bruce H.

si a) *1\ 1 : Pamela Moseley/DC/USEPA/US 08/28/2008 10:46 AM To Toni Krasmc/DC/USEPA/US@EPA cc Deena Vann/DC/USEPA/US@EPA bcc Subject Fw: LOI Submission of August 1,2008 O Toni, 1.

-1- Final Report Volume 1 of 6 (Text, Figures and Tables 1-51) Study Title An Oral (Gavage) Developmental Neurotoxicity and Thyroid Function Study of MTDID 208 in Rats Study Number WIL-180017 Data Requirement EPA OPPTS Guideline 870.6300; OECD Draft Guideline 426 Study Director Donald G.

AR226-2113 Industrial Hygiene Sample Date Range Concentration Range Action Level 1/1/86 100% 12X31/86 Sample Dt Sam ple# Duration Type Employee Name B T O : OS TEFLON LO C : 7D1 FINE PO W DER DRYER-EAST SID E #2 3/5/86 46263 950 Z 6/486 43264 360 z earns 46265 330 z 8/8/86 46273 390 z 8/5/88 40272 390 z 8/10/86 46271 360 z 8/116 46270 390 z 8/12/86 46269 350 z 8/13/86 46268 390 z 8/16/86 46267 390 z 8/25/86 46266 330 z 9/12/86 46275 360 z 9/15/86 46274 360 z 11/9/86 46276 330 z 11/22/86 46277 375 z Pere Chemical C-S/FC-143 C-S/FC-143 C-8/FC-143 C-8/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 C-8/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 C-S/FC-143 BTO: 03 TEFLON LOG: 702 FINE POWDER DRYER CONTROL ROOM (ALSO SEE TTFC1 8/12/86 36601 350 z C-S/FC-143 8/13/86 36600 390 z C-S/FC-143 8/16/86 36599 390 z C-S/FC-143 10/24/86 36602 300 z C-S/FC-143 11/13/86 36604 255 z C-S/FC-143 BTO: 08 TEFLON LOG: 703 FINE POWDER PACKOUT ROOM 2/26/86 34534 390 z 5/21/85 3453?

TRADE SECRET Study Title H-23960: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ID: DuPont-2922 AR226-3152 DuPont-2922 Author: Carol Finlay, B.A.